Evidence map›Paper›PMID 31201950›Full record

ArticleNeurobiology of aging2019

Analysis of pleiotropic genetic effects on cognitive impairment, systemic inflammation, and plasma lipids in the Health and Retirement Study.

Michael W Lutz, Ramon Casanova, Santiago Saldana, Maragatha Kuchibhatla, Brenda L Plassman, Kathleen M Hayden

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Likelihood ratio statistics for gene set enrichment in Alzheimer's disease pathways.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Article
  8. Article
  9. Article
  10. Shared genetic etiology underlying late-onset Alzheimer's disease and posttraumatic stress syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020
    Article
  11. Article
  12. Article
  13. Identification of anAlzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michael W LutzDepartment of Neurology, Duke University School of Medicine, Durham, NC, USA. Electronic address: Michael.lutz@duke.edu.
Ramon CasanovaDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Santiago SaldanaDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Maragatha KuchibhatlaDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Winston-Salem, NC, USA.
Brenda L PlassmanDepartment of Neurology, Duke University School of Medicine, Durham, NC, USA.
Kathleen M HaydenDepartment of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Duke University · USWake Forest University · US

Funding

Wake Forest Alzheimer's Disease Core CenterP30AG049638 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ESPELAND, MARK ANDREW · 2016 to 2020
$12.2M
Genes, environments, interactions, and cognitive decline in the HRSR01AG042633 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HAYDEN, KATHLEEN M · 2014 to 2016
$876k
NIA NIH HHS P30 AG049638NIA NIH HHS R01 AG042633
6 · The paper itself

Abstract

Variants associated with modulation of c-reactive protein (CRP) and plasma lipids have been investigated for polygenic overlap with Alzheimer's disease risk variants. We examined pleiotropic genetic effects on cognitive impairment conditioned on genetic variants (SNPs) associated with systemic inflammation as measured by CRP and with plasma lipids using data from the Health and Retirement Study. SNP enrichment was observed for cognitive impairment conditioned on the secondary phenotypes of plasma CRP and lipids. Fold enrichment of 100%-800% was observed for increasingly stringent p-value thresholds for SNPs associated with cognitive impairment conditional on plasma CRP, 80%-800% for low-density lipoprotein, and 80%-600% for total cholesterol. Significant associations (false discovery rate Q ≤ 0.05) between cognitive impairment, conditional with either CRP, low-density lipoprotein, or total cholesterol, were found for the locus on chromosome 19 that contains the APOE, TOMM40, APOC1, and PVRL2 genes. Relative numbers of significant SNPs in each of the genes differed by the conditional associations with the secondary phenotypes. Biological interpretation of both the genetic pleiotropy results and the individual genome-wide association results showed that the variants and proximal genes identified are involved in multiple pathological processes including cholesterol metabolism, inflammation, and mitochondrial transport. These findings are potentially important for Alzheimer's disease risk prediction and development of novel therapeutic approaches.

Indexed as

Alzheimer DiseaseApolipoprotein C-IApolipoproteins ECholesterolChromosomes, Human, Pair 19Cognitive DysfunctionC-Reactive ProteinForecastingGenome-Wide Association StudyHumansInflammationLipidsLipoproteins, LDLMembrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsNectinsAPOC1 protein, humanApolipoprotein C-IApolipoproteins ECholesterolC-Reactive ProteinLipidsLipoproteins, LDLMembrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsNECTIN2 protein, humanNectinsTOMM40 protein, humanCognitive impairmentGenetic pleiotropyHealth and retirement studyInflammation

Identifiers

PMID31201950
PMCPMC7233428
OpenAlexW2922401537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.